• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球癌症负担:预防重点。

The global burden of cancer: priorities for prevention.

机构信息

American Cancer Society, Research Department, 250 Williams Street, Northwest, Atlanta, GA 30303-1002, USA.

出版信息

Carcinogenesis. 2010 Jan;31(1):100-10. doi: 10.1093/carcin/bgp263. Epub 2009 Nov 24.

DOI:10.1093/carcin/bgp263
PMID:19934210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2802672/
Abstract

Despite decreases in the cancer death rates in high-resource countries, such as the USA, the number of cancer cases and deaths is projected to more than double worldwide over the next 20-40 years. Cancer is now the third leading cause of death, with >12 million new cases and 7.6 million cancer deaths estimated to have occurred globally in 2007. By 2030, it is projected that there will be approximately 26 million new cancer cases and 17 million cancer deaths per year. The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries. Under current trends, increased longevity in developing countries will nearly triple the number of people who survive to age 65 by 2050. This demographic shift is compounded by the entrenchment of modifiable risk factors such as smoking and obesity in many low-and medium-resource countries and by the slower decline in cancers related to chronic infections (especially stomach, liver and uterine cervix) in economically developing than in industrialized countries. This paper identifies several preventive measures that offer the most feasible approach to mitigate the anticipated global increase in cancer in countries that can least afford it. Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papilloma virus in countries where they are most needed.

摘要

尽管在高资源国家(如美国)癌症死亡率有所下降,但预计在未来 20-40 年内,全球癌症病例和死亡人数将增加一倍以上。癌症目前是第三大死亡原因,据估计,2007 年全球有超过 1200 万例新癌症病例和 760 万人死于癌症。到 2030 年,预计每年将有大约 2600 万例新癌症病例和 1700 万人死于癌症。预计这种增长将主要是由于人口的增长和老龄化推动的,在中低资源国家将最大。按照目前的趋势,发展中国家预期寿命的延长,将使到 2050 年 65 岁以上幸存人数增加近两倍。这种人口结构的转变加剧了许多中低资源国家可改变的风险因素(如吸烟和肥胖)的根深蒂固,以及与慢性感染(特别是胃癌、肝癌和宫颈癌)相关的癌症在经济发展中国家的下降速度比工业化国家慢。本文确定了一些预防措施,这些措施为那些最难以承受癌症负担的国家提供了减轻预期全球癌症增长的最可行方法。其中最重要的是需要加强国际烟草控制工作,并在最需要的国家增加乙型肝炎和人乳头瘤病毒疫苗的供应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/0abb63ef5b05/carcinbgp263f05_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/fc6e73d482b7/carcinbgp263f01_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/6c0aa4ff7205/carcinbgp263f02_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/b79f380142e2/carcinbgp263f03_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/6aed47f5141a/carcinbgp263f04_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/0abb63ef5b05/carcinbgp263f05_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/fc6e73d482b7/carcinbgp263f01_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/6c0aa4ff7205/carcinbgp263f02_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/b79f380142e2/carcinbgp263f03_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/6aed47f5141a/carcinbgp263f04_4c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a413/2802672/0abb63ef5b05/carcinbgp263f05_4c.jpg

相似文献

1
The global burden of cancer: priorities for prevention.全球癌症负担:预防重点。
Carcinogenesis. 2010 Jan;31(1):100-10. doi: 10.1093/carcin/bgp263. Epub 2009 Nov 24.
2
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.1990 - 2020年按病因划分的死亡率和残疾率的替代预测:全球疾病负担研究
Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.
3
Tuberculosis结核病
4
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
5
Projections of global mortality and burden of disease from 2002 to 2030.2002年至2030年全球死亡率及疾病负担预测。
PLoS Med. 2006 Nov;3(11):e442. doi: 10.1371/journal.pmed.0030442.
6
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
7
Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.欧洲的癌症、吸烟与过早死亡:一篇综述,包括1996年10月于赫尔辛基召开的欧洲癌症专家共识会议的建议
Lung Cancer. 1997 May;17(1):1-60. doi: 10.1016/s0169-5002(97)00648-x.
8
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden.1985年全球18种主要癌症的死亡率估计。对预防的启示及未来负担预测。
Int J Cancer. 1993 Dec 2;55(6):891-903. doi: 10.1002/ijc.2910550604.
9
Global Burden of Urologic Cancers, 1990-2013.全球泌尿生殖系统癌症负担,1990-2013 年。
Eur Urol. 2017 Mar;71(3):437-446. doi: 10.1016/j.eururo.2016.10.008. Epub 2016 Oct 28.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
The Cytochrome CYP4 in Breast and Other Cancers.细胞色素CYP4在乳腺癌及其他癌症中的作用
Biology (Basel). 2025 Jul 4;14(7):812. doi: 10.3390/biology14070812.
2
Hepatitis B Virus Genotypes and Subgenotypes Circulating in Belarus.白俄罗斯流行的乙型肝炎病毒基因型和亚基因型
Curr Issues Mol Biol. 2025 Jun 4;47(6):415. doi: 10.3390/cimb47060415.
3
Immunomodulatory and anticancer effects of moringa polyherbal infusions: potentials for preventive and therapeutic use.辣木复合草药浸剂的免疫调节和抗癌作用:预防和治疗用途的潜力

本文引用的文献

1
Avoidable global cancer deaths and total deaths from smoking.可避免的全球癌症死亡人数及吸烟导致的总死亡人数。
Nat Rev Cancer. 2009 Sep;9(9):655-64. doi: 10.1038/nrc2703. Epub 2009 Aug 20.
2
Economic policies for tobacco control in developing countries.发展中国家的烟草控制经济政策。
Salud Publica Mex. 2006;48 Suppl 1:S113-20. doi: 10.1590/s0036-36342006000700014.
3
The best practices: use of the guidelines by ten state tobacco control programs.最佳实践:十个州烟草控制项目对指南的使用
Front Immunol. 2025 Jun 19;16:1597602. doi: 10.3389/fimmu.2025.1597602. eCollection 2025.
4
Analyzing potential of next-generation probiotics in cancer management.分析新一代益生菌在癌症管理中的潜力。
Mol Biol Rep. 2025 Jun 27;52(1):646. doi: 10.1007/s11033-025-10737-3.
5
Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment.探索抗癌肽作为癌症治疗药物的潜力。
Res Pharm Sci. 2025 Mar 31;20(2):165-187. doi: 10.4103/RPS.RPS_75_24. eCollection 2025 Apr.
6
Synthesis and Biomedical Based Applications of Selenium Nanoparticles: A Comprehensive Review.硒纳米颗粒的合成及其基于生物医学的应用:综述
Indian J Microbiol. 2025 Mar;65(1):204-215. doi: 10.1007/s12088-024-01302-w. Epub 2024 May 22.
7
Assessing the impact of gout on cancer risk and the role of healthy lifestyles.评估痛风对癌症风险的影响以及健康生活方式的作用。
Front Oncol. 2025 Apr 28;15:1557175. doi: 10.3389/fonc.2025.1557175. eCollection 2025.
8
Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies.异常剪接作为癌症治疗耐药的一种机制
Cancers (Basel). 2025 Apr 21;17(8):1381. doi: 10.3390/cancers17081381.
9
Personalized Lifestyle Interventions for Prevention and Treatment of Obesity-Related Cancers: A Call to Action.个性化生活方式干预预防和治疗肥胖相关癌症:行动呼吁。
Cancers (Basel). 2025 Apr 8;17(8):1255. doi: 10.3390/cancers17081255.
10
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis.炎症在癌症中的作用:肿瘤起始、进展和转移的机制
Cells. 2025 Mar 25;14(7):488. doi: 10.3390/cells14070488.
Am J Prev Med. 2006 Oct;31(4):300-6. doi: 10.1016/j.amepre.2006.06.015. Epub 2006 Aug 28.
4
Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey.香烟警示标签在告知吸烟者吸烟风险方面的有效性:国际烟草控制(ITC)四国调查结果
Tob Control. 2006 Jun;15 Suppl 3(Suppl 3):iii19-25. doi: 10.1136/tc.2005.012294.
5
The global health burden of infection-associated cancers in the year 2002.2002年感染相关癌症的全球健康负担。
Int J Cancer. 2006 Jun 15;118(12):3030-44. doi: 10.1002/ijc.21731.
6
Predicting the future burden of cancer.预测癌症的未来负担。
Nat Rev Cancer. 2006 Jan;6(1):63-74. doi: 10.1038/nrc1781.
7
Role of smoking in global and regional cancer epidemiology: current patterns and data needs.吸烟在全球及区域癌症流行病学中的作用:当前模式与数据需求
Int J Cancer. 2005 Oct 10;116(6):963-71. doi: 10.1002/ijc.21100.
8
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
9
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.维生素K2在病毒性肝硬化女性肝细胞癌发生中的作用
JAMA. 2004 Jul 21;292(3):358-61. doi: 10.1001/jama.292.3.358.
10
AIDS-related non-Hodgkin's lymphoma: etiology, epidemiology, and impact of highly active antiretroviral therapy.艾滋病相关非霍奇金淋巴瘤:病因、流行病学及高效抗逆转录病毒治疗的影响
Leuk Lymphoma. 2003;44 Suppl 3:S63-8. doi: 10.1080/10428190310001623748.